Carnage in Less Invasive Diabetes Testing

Plenty of start-ups have attempted to develop less-invasive systems for diabetes testing with very little success. MiniMed Inc. appears to be the farthest along; it is awaiting FDA approval for a continuous real-time blood glucose monitor which can be implanted under the skin.

Diabetes testing is one of the best markets in diagnostics, and Roche , Abbott Laboratories Inc. , Johnson & Johnson , and Bayer AG are all reaping its benefits. One big concern: a new entrant with a less-invasive system will obsolete their products.

Not to worry, at least for now. Plenty of start-ups have tried to develop these systems, with very little success;...

More from Archive

More from Medtech Insight